AI-driven Drug Optimization
Design the next compound set with validated structural context, multi-parameter evidence and project-specific learning
From receptor validation and molecular design to ADMET, translational exposure and DMTA decisions, MedMap helps discovery teams decide what to make next, what to stop and why.
Bring the current project question. Define the most useful next decision workflow.
Ranked, diverse compound set
Balanced candidates across distinct design hypotheses
Candidate-specific rationale
Strengths, liabilities, edits and uncertainty
Next-cycle decision plan
What to synthesize, test, stop and validate
Four Decision Services
Start with the question your project needs to answer
Each service can be used independently or connected within one traceable discovery program.
Small-Molecule Design
What should we design and synthesize next?
Project-specific generation, hierarchical filtering and adaptive portfolio selection.
Receptor Workbench
Can the structural protocol support ranking?
Multi-receptor preparation, reference-ligand redocking and explicit diagnostics.
Translational PK/PD
Will compound properties translate into exposure and effect?
Systemic/tumor exposure, target occupancy and efficacy scenarios.
ADC Systems Optimization
How should the complete ADC construct be optimized?
Target, antibody, linker, payload, DAR, exposure and safety-window optimization.
Discovery Decision Workflow
From project question to the next experimental cycle
1Project question
2Validated context
3Design hypothesis
4Hierarchical filters
5Multi-objective selection
6Translational scenarios
7DMTA decision
Why MedMap
A decision architecture—not a collection of isolated AI models
Validate receptors and protocols before optimization
Translate molecular properties into exposure and target-engagement scenarios
Keep design hypotheses and compound-series context visible
Use project history to refine the next DMTA cycle
Balance potency, ADMET, synthesis, diversity and novelty
Separate platform outputs from research, managed and legal review boundaries
From molecular ideas to the next experimental decision
Discuss a focused project review, pilot scope or complete optimization program with MedMap.
Contact MedMap